Latest filing published 23 Feb 2026 for Pulse Biosciences, INC., €6,455.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +57.5%Entry US$2.47 · Close at T+365 US$3.89
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kevin Patrick Danahy: trading record in brief
All filings by Kevin Patrick Danahy on record concern Pulse Biosciences, Inc., in the capacity of senior executive. The record holds 8 filings, for trades running from 30 September 2022 to 18 February 2026.
No open-market sale appears; the market trades are 2 purchases worth €44k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 5 option exercises.
On 23 February 2026 came the latest disclosure, an option exercise for €6,455 in Pulse Biosciences, Inc. The clock since the last published purchase (17 November 2023) now reads 1,087 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kevin Patrick Danahy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$1.534.8% of flowCommon StockSEC:0001437749-26-005144:0
- 20,000 shares@ US$1.530.0009% mcap19.2% of flowCommon StockSEC:0001437749-26-004438:0
- 20,000 shares@ US$1.530.0009% mcap19.3% of flowCommon StockSEC:0001437749-26-003840:0
- 4,600 shares@ US$1.530.0002% mcap4.5% of flowCommon StockSEC:0001437749-25-030665:0
- 20,000 shares@ US$1.5319.4% of flowCommon StockSEC:0001437749-25-029646:0
- 650 sharesCommon StockSEC:0001437749-24-022356:0
- 4,781 shares@ US$6.519921.4% of flowCommon StockSEC:0001437749-23-032410:0Canonical exit: 14 Feb 2024 (T+90)
- 6,500 shares@ US$2.3011.4% of flowCommon StockSEC:0001839882-22-022698:0Canonical exit: 29 Dec 2022 (T+90)
8 of 8 declarations
